Recombinant IL-6R (Tocilizumab Biosimilar) 抗体
Our Local Distributor
北京 101111
Quick Overview for Recombinant IL-6R (Tocilizumab Biosimilar) 抗体 (ABIN7487791)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
质量等级
-
-
Expression System
- Mammalian cells
-
原理
- Tocilizumab Biosimilar - Anti-IL-6R mAb
-
产品特性
- Antibody Type: IgG1Kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1 kappa
-
-
anti-IL-6R (Tocilizumab Biosimilar) antibody
Research Grade 适用: 人 ELISA, FACS 宿主: Humanized Monoclonal unconjugated Recombinant Antibody
anti-IL-6R (Tocilizumab Biosimilar) antibody适用: 人 ELISA, InhA 宿主: 兔 Chimeric RhPM-1 unconjugated Recombinant Antibody
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- 4 °C,-20 °C
-
储存方法
- 4°C for short term, -20°C for long term
-
-
- IL-6R (Tocilizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
Tocilizumab
Tocilizumab, also known as atlizumab, is a recombinant humanized, anti-human monoclonal antibody (mAb) of the immunoglobulin G1κ subclass directed against soluble and membrane-bound interleukin-6 (IL-6) receptor (IL-6R) which plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer. -
CAS-编号
- 375823-41-9
抗原
-
